Cargando…

Antagonistic Functions of Androgen Receptor and NF-κB in Prostate Cancer—Experimental and Computational Analyses

SIMPLE SUMMARY: The standard treatment of metastasizing prostate cancer by androgen receptor blockers fails to provide a curative therapy, with most of the patients dying from tumor relapse. We show by experimental and computational methods that androgen receptor blockade upregulates inflammatory pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basílio, José, Hochreiter, Bernhard, Hoesel, Bastian, Sheshori, Emira, Mussbacher, Marion, Hanel, Rudolf, Schmid, Johannes A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776608/ https://www.ncbi.nlm.nih.gov/pubmed/36551650 http://dx.doi.org/10.3390/cancers14246164

Ejemplares similares

Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis
por: Mussbacher, Marion, et al.
Publicado: (2019)

NF-κB in monocytes and macrophages – an inflammatory master regulator in multitalented immune cells
por: Mussbacher, Marion, et al.
Publicado: (2023)

The complexity of NF-κB signaling in inflammation and cancer
por: Hoesel, Bastian, et al.
Publicado: (2013)

Sequence-function correlations and dynamics of ERG isoforms. ERG8 is the black sheep of the family
por: Hoesel, Bastian, et al.
Publicado: (2015)

Androgen receptor dampens tissue factor expression via nuclear factor‐κB and early growth response protein 1
por: Hoesel, B., et al.
Publicado: (2018)

The inflammatory kinase IKKα phosphorylates and stabilizes c-Myc and enhances its activity
por: Moser, Bernhard, et al.
Publicado: (2021)

Genetic platelet depletion is superior in platelet transfusion compared to current models
por: Salzmann, Manuel, et al.
Publicado: (2020)

Genetic platelet depletion is superior in platelet transfusion compared to current models
por: Salzmann, Manuel, et al.
Publicado: (2020)

Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer
por: Culig, Zoran
Publicado: (2021)

CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
por: Hwang, Justin H., et al.
Publicado: (2019)

Targeting Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in Prostate Cancer
por: Khurana, Namrata, et al.
Publicado: (2018)

Inverse baseline expression pattern of the NEP/neuropeptides and NFκB/proteasome pathways in androgen-dependent and androgen-independent prostate cancer cells
por: Patrikidou, Anna, et al.
Publicado: (2011)

Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-κB cistrome to reprogram the prostate cancer cell transcriptome
por: Malinen, Marjo, et al.
Publicado: (2017)

Second generation androgen receptor antagonists and challenges in prostate cancer treatment
por: Chen, Yanhua, et al.
Publicado: (2022)

Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia
por: D’Amico, Ramona, et al.
Publicado: (2021)

Androgen Receptor Upregulates Mucosa-Associated Lymphoid Tissue 1 to Induce NF-κB Activity via Androgen-Dependent and -Independent Pathways in Prostate Carcinoma Cells
por: Chang, Kang-Shuo, et al.
Publicado: (2023)

Fatty Acid Inhibition Sensitizes Androgen-Dependent and -Independent Prostate Cancer to Radiotherapy via FASN/NF-κB Pathway
por: Chuang, Hui-Yen, et al.
Publicado: (2019)

Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer
por: Kokal, Miriam, et al.
Publicado: (2020)

Extracellular Vesicles Linking Inflammation, Cancer and Thrombotic Risks
por: Beck, Sarah, et al.
Publicado: (2022)

Fluorescence colocalization microscopy analysis can be improved by combining object‐recognition with pixel‐intensity‐correlation
por: Moser, Bernhard, et al.
Publicado: (2016)

Advanced FRET normalization allows quantitative analysis of protein interactions including stoichiometries and relative affinities in living cells
por: Hochreiter, Bernhard, et al.
Publicado: (2019)

Small Molecule Antagonists of the Nuclear Androgen Receptor for the Treatment of Castration-Resistant Prostate Cancer
por: Johnson, James K., et al.
Publicado: (2016)

Second-Generation Androgen Receptor Antagonists as Hormonal Therapeutics for Three Forms of Prostate Cancer
por: Rajaram, Pravien, et al.
Publicado: (2020)

Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models
por: Sugawara, Tatsuo, et al.
Publicado: (2019)

Influence of Androgen Receptor Antagonist MDV3100 Therapy on Rats With Benign Prostatic Hyperplasia
por: Yang, Minggen, et al.
Publicado: (2021)

Synthesis of Hydantoin Androgen Receptor Antagonists and Study on Their Antagonistic Activity
por: Ma, Longjun, et al.
Publicado: (2022)

Fluorescent Proteins as Genetically Encoded FRET Biosensors in Life Sciences
por: Hochreiter, Bernhard, et al.
Publicado: (2015)

Addendum: Hochreiter, B.; Pardo-Garcia, A.; Schmid, J.A. Fluorescent Proteins as Genetically Encoded FRET Biosensors in Life Sciences. Sensors 2015, 15, 26281–26314
por: Hochreiter, Bernhard, et al.
Publicado: (2015)

Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer A systematic review with meta-analysis
por: Kunath, Frank, et al.
Publicado: (2015)

Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone.
por: Jungwirth, A., et al.
Publicado: (1997)

MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer
por: Tovar, Christian, et al.
Publicado: (2011)

Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer
por: Kregel, Steven, et al.
Publicado: (2016)

Cheminformatic Analysis and Machine Learning Modeling to Investigate Androgen Receptor Antagonists to Combat Prostate Cancer
por: Yu, Tianshi, et al.
Publicado: (2023)

Systems Pharmacology Modeling of Prostate‐Specific Antigen in Patients With Prostate Cancer Treated With an Androgen Receptor Antagonist and Down‐Regulator
por: Mistry, HB, et al.
Publicado: (2016)

CK2 Pro-Survival Role in Prostate Cancer Is Mediated via Maintenance and Promotion of Androgen Receptor and NFκB p65 Expression
por: Trembley, Janeen H., et al.
Publicado: (2019)

A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
por: Miyazawa, Yoshiyuki, et al.
Publicado: (2017)

SUN-139 Luminescence-Based Drug Screen for Novel Androgen Receptor Antagonists for Prostate Cancer Therapy
por: Azur, Romie Angelo G, et al.
Publicado: (2020)

H3K9 methylation drives resistance to androgen receptor–antagonist therapy in prostate cancer
por: Baratchian, Mehdi, et al.
Publicado: (2022)

Androgen receptor agonist and antagonist reduce response of cytokine‐induced killer cells on prostate cancer cells
por: Pungsrinont, Thanakorn, et al.
Publicado: (2023)

Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic Activities
por: Yao, Hailan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1qb4t07lesg6viqfiav1hdognh